Skip to content

Goodwill at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$47.81M0.0%
Zymeworks logo
ZymeworksZYME
$12.02M0.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$577.1M+39.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
$9.12B+3.1%
Biohaven logo
BiohavenBHVN
$1.39M0.0%
AbbVie logo
AbbVieABBV
$35.57B+0.8%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's goodwill?
ADMA Biologics (ADMA) reported goodwill of $3.53M in Q1 2026.
How has ADMA Biologics's goodwill changed year-over-year?
ADMA Biologics's goodwill decreased by 0.0% year-over-year, from $3.53M to $3.53M.
What is the long-term trend for ADMA Biologics's goodwill?
Over 5 years (2020 to 2025), ADMA Biologics's goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $3.53M to $3.53M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.